Senior Medical Director EMEA, Neurosciences

Why Join Us

Be a hero for our rare disease patients At Ultragenyx, we fundamentally believe that taking real impactful action to care for the needs of patients and our people is always the right thing to do. To achieve this goal, our vision is to lead the future of rare disease medicine. For us, this means going where other biopharma companies won’t go – challenging the status quo and creating a new model that advances our field so more patients and caregivers can benefit from life-changing treatments.

We do this by following the science, applying a novel rapid development approach, making innovative medicines at fair and reasonable prices, and creating a collaborative ecosystem to reach patients in ways that are most meaningful for them. Our commitment and care for patients extends to our people, so culture is an essential cornerstone for Ultragenyx. We remain continuously focused on creating a supportive and inclusive environment of profound learning and growth – so employees can thrive in all areas of their lives, in and outside of work.

Ultimately, we want to be an organization where we would be proud for our family, friends and children to work. If you want to have a meaningful impact, do the best work of your career, and grow a lot, both professionally and personally, come join our team . Position Summary: ultra focused – Work together to fearlessly uncover new possibilities The Senior Medical Director, Neuroscience – EMEA is a strategic medical leader responsible for the development and execution of the regional medical affairs strategy for the disease program across EMEA.

This role partners closely with global, regional, and local cross-functional teams to ensure alignment with development, evidence generation, and commercialization strategies. The role will lead pre-launch and launch readiness activities, shape the integrated evidence plan, and build strong external partnerships with key opinion leaders, investigators, and patient communities to advance scientific understanding and improve outcomes for people living with this rare neurogenetic condition. Work Model: Flex: This role will typically require onsite work 2-3 days each week, or more depending on business needs.

In many locations, the business will set certain days each week that Flex employees are required to be onsite.

Responsibilities

: Strategic Leadership: Define and lead the EMEA medical strategy for Angelman syndrome, aligned with global strategy and tailored to regional needs; contribute to global medical and cross-functional governance. Provide strategic input into clinical development, lifecycle management, and pipeline prioritization. Evidence Generation dissemination Strategy: Active contributor to the Integrated Evidence Generation Plan (IEP), including real-world evidence, representing the EMEA needs and evidence gaps.

Ensure generation of clinically meaningful and payer-relevant evidence for this therapeutic area. Contributes to publication strategy, data dissemination, and scientific communications. Launch Excellence: Lead EMEA medical launch planning and execution, including disease awareness, diagnostic pathways, and treatment paradigm evolution and ensure medical readiness across EMEA Clusters.

Partner with market access to support HTA submissions and value proposition. External Engagement: Build and maintain strong relationships with Key Opinion Leaders (KOLs), Clinical investigators, Scientific societies and contribute to Patient advocacy groups engagements in close collaboration with Patient Advocacy. Act as a scientific ambassador for the therapeutic area within the region.

Cross-Functional Collaboration: Partner closely with Global Medical Affairs, Clinical Development, Regulatory Affairs, Market Access HEOR, Commercial and Diagnostics teams, enabling integrated execution across development-to-commercial continuum.